Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-02
DOI
10.3389/fmed.2020.586221
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV
- (2020) Xingguang Li et al. JOURNAL OF MEDICAL VIROLOGY
- Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel
- (2020) Isaac I Bogoch et al. JOURNAL OF TRAVEL MEDICINE
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?
- (2020) Charleen Yeo et al. Lancet Gastroenterology & Hepatology
- COVID‐19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine
- (2020) Francesco Fontana et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter
- (2020) Marcus R. Pereira et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
- (2020) R. Marfella et al. DIABETES & METABOLISM
- Clinical Insights into the Gastrointestinal Manifestations of COVID-19
- (2020) Jonathan Kopel et al. DIGESTIVE DISEASES AND SCIENCES
- COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies
- (2020) Abhilash Perisetti et al. Digestive Endoscopy
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
- (2020) Valentina Morena et al. European Journal of Internal Medicine
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care
- (2020) Luca Quartuccio et al. JOURNAL OF CLINICAL VIROLOGY
- COVID-19: Abnormal liver function tests
- (2020) Qingxian Cai et al. JOURNAL OF HEPATOLOGY
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Tocilizumab for the treatment of severe coronavirus disease 2019
- (2020) Rand Alattar et al. JOURNAL OF MEDICAL VIROLOGY
- Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID‐19
- (2020) Yong Gao et al. JOURNAL OF MEDICAL VIROLOGY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
- (2020) T. Klopfenstein et al. MEDECINE ET MALADIES INFECTIEUSES
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful recovery from severe COVID‐19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab
- (2020) Andrea Lauterio et al. Transplant Infectious Disease
- Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
- (2020) Marta Colaneri et al. Microorganisms
- COVID-19 pathophysiology: A review
- (2020) Koichi Yuki et al. CLINICAL IMMUNOLOGY
- Tocilizumab for severe COVID-19: a systematic review and meta-analysis
- (2020) Shao-Huan Lan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
- (2020) Ali Hassoun et al. JOURNAL OF CLINICAL VIROLOGY
- Tocilizumab challenge: A series of cytokine storm therapy experiences in hospitalized COVID‐19 pneumonia patients
- (2020) Betul Borku Uysal et al. JOURNAL OF MEDICAL VIROLOGY
- A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
- (2020) Federico Alberici et al. KIDNEY INTERNATIONAL
- Estimates of the severity of coronavirus disease 2019: a model-based analysis
- (2020) Robert Verity et al. LANCET INFECTIOUS DISEASES
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
- (2020) Andrew Ip et al. PLoS One
- Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study
- (2020) G Rojas-Marte et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
- (2020) Jonathan Rilinger et al. Trials
- Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
- (2020) Bastiaan Maes et al. Trials
- Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis
- (2020) Umesha Boregowda et al. Frontiers in Medicine
- Tocilizumab
- (2010) Adith Venkiteshwaran mAbs
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started